The need for digital transformation and a response model for COVID-19 were among the topics discussed in a recent digital debate
COVID-19 has upended our healthcare system and thrust pharmaceutical product patient support programs (PSPs) onto the front lines of treatment management.
COVID-19 has fundamentally changed how we deliver conferences in 2020
The social-distancing restrictions of the COVID-19 pandemic, in addition to the redirection of hospital resources, may pose extensive burdens on clinical trials.
The ongoing global health crisis due to the coronavirus pandemic is going to have a lasting impact on all of our lives. A recent article in Forbes goes in depth on these topics, talking about the positive impact that DTx can have on fragile patients, physicians and health systems’ sustainability
A trending outcome of COVID-19 is that most 2020 conferences will adapt by moving to virtual settings